Bupropion and Cigarette-Related Cues in Smokers
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Apr 17, 2019
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Treatment-seeking cigarette smoker
- • Meet DSM-IV criteria for nicotine dependence
- • Negative result on urine test for drug use during screening
- Exclusion Criteria:
- • History of any Axis I psychiatric diagnosis other than nicotine dependence
- • Medical conditions that might affect brain function
- • Current use of medications that could alter brain function
- • Pregnancy
- • Current illicit drug use other than occasional use of marijuana
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials